Arkolith/Insider Trading/VAXX/Form 4

Guirakhoo Farshad

Chief Scientific OfficerVaxxinity, Inc. (VAXX) · full profile →Form 4 · filed May 5, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 3, 2022Option exercise(M)10K$0.57$6K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 3, 2022Option exercise(M)10K—$0117K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-016779) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML